Dedicated to Therapeutic Progress
For 40 years, Servier India has been committed to improving patients’ lives through therapeutic progress. Guided by science and driven by patient needs, we deliver innovative healthcare solutions across cardiometabolism, venous diseases, and oncology.
As part of the global Servier Group, we combine scientific excellence with a deep sense of responsibility, working alongside healthcare professionals, partners, and communities to improve health outcomes and make a meaningful impact. Together, we continue to advance care, foster innovation, and create a healthier future for patients across India.
OUR SOLUTIONS FOR PATIENTS
33rd
largest pharmaceutical group worldwide¹
2nd largest pharmaceutical group
in France¹
Over 20000
employees
20%
Close to 20% of revenue from brand-name
medicines invested in R&D each year
6.9 billion
euros turnover in 2024/25
3 therapeutic areas
oncology,
cardiometabolism
& venous diseases, neurology
[1] IQVIA, Analytics Link / World 84 countries – MAT Q1-2026
